Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
38.5M
-
Shares change
-
+3.32M
-
Total reported value, excl. options
-
$622M
-
Value change
-
+$52.9M
-
Put/Call ratio
-
0.2
-
Number of buys
-
60
-
Number of sells
-
-60
-
Price
-
$16.18
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2014
151 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2014.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.5M shares
of 58.9M outstanding shares and own 65.36% of the company stock.
Largest 10 shareholders include FMR LLC (4.57M shares), BAKER BROS. ADVISORS LP (4.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.43M shares), Palo Alto Investors, LLC (3.24M shares), PAULSON & CO INC (3.2M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.74M shares), Signpost Capital Advisors, LP (1.69M shares), State Street Corp (1.55M shares), Invesco Ltd. (1.35M shares), and BlackRock Fund Advisors (1.24M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.